The dosages below are from completed studies on humans or on clinical trials on humans. In general, they represent safe dosages for most people. Please be aware that there is often an exponentail effectiveness. Talking half the dosage may only see 1/4 of the effect. We are not looking at minimum effective dosage, but maximum [safe] dosage used in clinical trials and studies.
If a study has been completed, the dosage will be marked Ineffective or Effective -- depending if statistically changes were reported by the study.
This is not medical advice (see your MD for that). It is a reporting on dosages that some MDs have used.
|.||Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients||2 g/day|
|.||Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy (PRIME)||2 g/day|
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2022 Lassesen Consulting, LLC , DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.